(Q80983248)
Statements
Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy (English)
Anthony V D'Amico
Judd Moul
Peter R Carroll
Leon Sun
Deborah Lubeck
S42-6; discussion S46-7